This free two-part activity focuses on the incidence of melanoma in adolescents and young adults, and presents a patient case of a 26-year-old female from diagnosis of initial melanoma through to the end stages of disease. Expert faculty discuss issues related to prevention, adjuvant therapy options, treatment strategies, and palliative care issues.
Section 1 introduces a case of newly diagnosed, early stage, curable disease. Issues of prevention, detection (recognizing new disease), and early management are addressed, as well as potential therapeutics and related toxicities of these therapies.
- Understand the factors related to increased incidence of melanoma among the adolescent and young adult population.
- Apply knowledge of the ABCD signs of melanoma presentation to diagnosing patients in clinical practice
- Enhance awareness of the management options for primary and early-stage melanoma
- Identify the adjuvant therapy options for stage 1 and 2 melanoma
Section 2 covers recurrence of disease in the patient from section 1. New emerging therapies for stage 3+ disease are discussed, as is palliative treatment for end-stage disease.
- Identify distinct genetic alterations in melanoma and apply knowledge to treatment options for patients
- Describe the benefits and side-effects of targeted therapy, immunotherapy, and chemotherapy for the treatment of late-stage melanoma
- Understand the role of palliative care during the treatment of late-stage melanoma
CME credit is available for this course.
ACGME Competencies addressed: Medical Knowledge; Practice-based Learning & Improvement; Interpersonal & Communications Skills
This activity is co-sponsored by the LIVESTRONG Foundation, the Commission on Cancer/American College of Surgeons, Critical Mass: The Young Adult Cancer Alliance, the Association of Physician Assistants in Oncology, the American Society of Pediatric Hematology/Oncology, and the Conquer Cancer Foundation of the American Society of Clinical Oncology.
This initiative was supported by the Cooperative Agreement 5U50DP001689-05 from The Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.
This course, as well as others in the Focus Under Forty Series, was also supported by the LIVESTRONG Foundation.